Jonathan Garst Orozco

Jonathan Garst Orozco has a diverse work experience with a focus on strategy consulting and scientific research. Jonathan is currently the Head of Competitive Intelligence - Neuroscience at Cerevel Therapeutics since November 2021. Prior to this role, they worked as an Engagement Manager at Prescient Healthcare Group from October 2020 to November 2021. Before that, they were a Strategy Consultant at Catenion from March 2020 to October 2020. Jonathan also has experience as a freelance Strategy Consultant from February 2019 to March 2020. Jonathan worked as a Senior Scientist at VL51 inc., a Flagship Pioneering Company, from April 2018 to January 2019, and at Pfizer from July 2014 to April 2018. Jonathan's earlier experience includes serving as a Doctoral Student at Harvard University from 2007 to 2014, a Research Associate at KU Leuven in 2008, and a Research Assistant at Washington University in St. Louis from 2004 to 2007.

Jonathan Garst Orozco has a strong educational background in the field of neuroscience. Jonathan pursued their Bachelor of Arts degree in Neurobiology from Washington University in St. Louis, from 2003 to 2007. Following this, they went on to earn a Doctor of Philosophy (PhD) in Neuroscience from Harvard University, studying there from 2008 to 2014. These two degrees reflect their dedication and expertise in the field of neuroscience.